Our team is well positioned to leverage our global resources and match emerging growth companies with high-quality financial and strategic investors. Our skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences / biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.
Using our distribution capabilities, we target a specific group of investors and organize meetings that can maximize management’s time. In our experience, an orchestrated process helps to streamline the transaction and thereby its competitiveness. A key to our success is aligning ourselves with top investors, strategic thinkers, entrepreneurs and executives around the world.
Latest Maxim Group News
VCV Digital Technology to Become Publicly Traded Via Business Combination with Fortune Rise Acquisition Corporation
VCV Power Sigma, Inc. (“Sigma”) and VCV Power Gamma, Inc. (“Gamma” and, together with Sigma,
Maxim Group LLC, a leading full service investment banking, securities and wealth management firm today
Maxim Group LLC acts as Sole placement agent for Lianluo Smart Limited in its $3.4 Million Registered Direct Offering
Lianluo Smart Limited (“Lianluo Smart” or the “Company”) (NASDAQ: LLIT), a China based professional smart